BlackRock Advisors’s Core Laboratories CLB Stock Holding History

BlackRock Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$5.23M	Buy	43,544 +10,863	+33%	+$1.2M	0.01%	1122
2016 Q3	$3.67M	Buy	32,681 +2,794	+9%	+$322K	﹤0.01%	1224
2016 Q2	$3.7M	Sell	29,887 -1,587	-5%	-$192K	﹤0.01%	1220
2016 Q1	$3.54M	Sell	31,474 -395	-1%	-$41K	﹤0.01%	1222
2015 Q4	$3.46M	Sell	31,869 -408	-1%	-$46.7K	﹤0.01%	1219
2015 Q3	$3.22M	Buy	32,277 +25,819	+400%	+$2.81M	﹤0.01%	1226
2015 Q2	$736K	Hold	6,458	–	–	﹤0.01%	1881
2015 Q1	$675K	Hold	6,458	–	–	﹤0.01%	1845
2014 Q4	$777K	Hold	6,458	–	–	﹤0.01%	1668
2014 Q3	$945K	Sell	6,458 -38,734	-86%	-$5.98M	﹤0.01%	1470
2014 Q2	$7.55M	Buy	45,192 +4,808	+12%	+$855K	0.01%	867
2014 Q1	$8.01M	Buy	40,384 +207	+0.5%	+$39.1K	0.01%	862
2013 Q4	$7.67M	Sell	40,177 -41,687	-51%	-$7.76M	0.01%	881
2013 Q3	$13.9M	Buy	81,864 +6,049	+8%	+$939K	0.01%	684
2013 Q2	$11.5M	Buy	+75,815	New	+$10.7M	0.01%	726

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BlackRock Advisors's CLB Position: Q4 2016 in Review

BlackRock Advisors increased its Core Laboratories (CLB) stake by 33% in Q4 2016, buying an estimated $1.2M and bringing the position to 43,544 shares worth $5.23M. The position accounts for 0.01% of the portfolio, ranked #1122.

BlackRock Advisors first reported a position in CLB in Q2 2013 and has held it in 15 quarters since. The position peaked at $13.9M in Q3 2013. 372 funds tracked by Wall St. Rank hold CLB as of Q4 2016.

BlackRock Advisors held 43,544 shares of Core Laboratories worth $5.23M as of Q4 2016.
BlackRock Advisors bought 10,863 Core Laboratories shares in Q4 2016, an estimated $1.2M.
Core Laboratories made up 0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1122 holding.
BlackRock Advisors first reported a position in Core Laboratories in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Core Laboratories position peaked at $13.9M in Q3 2013.
372 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.